Candida soluble cell wall β-D-glucan induces lung inflammation in mice

International Journal of Immunopathology and Pharmacology

Volumn 20, Issue 3, 2007, Pages 499-508

  Inoue, K ^a   Takano, Hirohisa ^a,b   Oda, T ^c   Yanagisawa, R ^a   Tamura, H ^c   Ohno, N ^d   Adachi, Y ^d   Ishibashi, K ^d   Yoshikawa, T ^b  

^a NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c SEIKAGAKU CORPORATION   (Japan)

^d TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Beta D glucan; Candida; Lung inflammation; STAT 6

Indexed keywords

BETA DEXTRO GLUCAN; EOTAXIN; GLUCAN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; RANTES; STAT6 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CELL WALL; CONTROLLED STUDY; EOSINOPHIL; IMMUNE RESPONSE; IMMUNE SYSTEM; LUNG MYCOSIS; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION;

EID: 34948833597     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200702000308     Document Type: Article

References (41)

1. Fridkin S.K. and W.R. Jarvis. 1996. Epidemiology of nosocomial fungal infections. Clin. Microbiol. Rev. 9:499.
2. LaRocco M.T. and S.J. Burgert. 1997. Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation. Clin. Microbiol. Rev. 10:277.
3. Patel R. and C.V. Paya. 1997. Infections in solid-organ transplant recipients. Clin. Microbiol. Rev. 10:86.
4. Walsh T.J., C. Gonzalez, E. Roilides, B.U. Mueller, N. Ali, L.L. Lewis, T.O. Whitcomb, D.J. Marshall and P.A. Pizzo. 1995. Fungemia in children infected with the human immunodeficiency virus: new epidemiologic patterns, emerging pathogens, and improved outcome with antifungal therapy. Clin. Infect. Dis. 20:900.
5. Fraser V.J., M. Jones, J. Dunkel, S. Storfer, G. Medoff and W.C. Dunagan. 1992. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin. Infect. Dis. 15:414.
6. Telenti A., J.M. Steckelberg, L. Stockman, R.S. Edson and G.D. Roberts. 1991. Quantitative blood cultures in candidemia. Mayo Clin. Proc. 66:1120.
7. Katz S., J.L. Grosfeld, W.J. Folkening, R.S. Rosenthal and G.J. Merkel. 1992. Initial organ localisation of blood-borne Candida albicans in a rat model of disseminated candidosis. J. Med. Microbiol. 37:291.
8. Polak-Wyss A. 1991. Protective effect of human granulocyte colony-stimulating factor (hG-CSF) on Cryptococcus and Aspergillus infections in normal and immunosuppressed mice. Mycoses 34:205.
9. Sawyer R.T. and A.G. Harmsen. 1989. The relative contribution of resident pulmonary alveolar macrophage and inflammatory polymorphonuclear neutrophils in host resistance to pulmonary infection by Candida albicans. Mycopathologia 108:95.
10. Aratani Y., H. Koyama, S. Nyui, K. Suzuki, F. Kura and N. Maeda. 1999. Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase. Infect. Immun. 67:1828.
11. Aratani Y., F. Kura, H. Watanabe, H. Akagawa, Y. Takano, K. Suzuki, M.C. Dinauer, N. Maeda and H. Koyama. 2002. Critical role of myeloperoxidase and nicotinamide adenine dinucleotide phosphate-oxidase in high-burden systemic infection of mice with Candida albicans. J. Infect. Dis. 185:1833.
12. Lechner A.J., K.E. Lamprech, L.H. Potthoff, T.L. Tredway and G.M. Matuschak. 1994. Recombinant GM-CSF reduces lung injury and mortality during neutropenic Candida sepsis. Am. J. Physiol. 266:561.
13. Takakura N., Y. Sato, H. Ishibashi, H. Oshima, K. Uchida, H. Yamaguchi and S. Abe. 2003. A novel murine model of oral candidiasis with local symptoms characteristic of oral thrush. Microbiol. Immunol. 47:321.
14. Raetz C.R. 1990. Biochemistry of endotoxins. Annu. Rev. Biochem. 59:129.
15. De Kimpe S.J., M. Kengatharan, C. Thiemermann and J.R. Vane. 1995. The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc. Natl. Acad. Sci. USA 92:10359.
16. Gupta D., Y.P. Jin and R. Dziarski. 1995. Peptidoglycan induces transcription and secretion of TNF-alpha and activation of lyn, extracellular signal-regulated kinase, and rsk signal transduction proteins in mouse macrophages. J. Immunol. 155:2620.
17. Juffermans N.P., A. Verbon, J.T. Belisle, P.J. Hill, P. Speelman, S.J. van Deventer and T. van der Poll. 2000. Mycobacterial lipoarabinomannan induces an inflammatory response in the mouse lung. A role for interleukin-1. Am. J. Respir. Crit. Care Med. 162:486.
18. Lebron F., R. Vassallo, V. Puri and A.H. Limper. 2003. Pneumocystis carinii cell wall beta-glucans initiate macrophage inflammatory responses through NF-kappaB activation. J. Biol. Chem. 278:25001.
19. Ohno N., M. Uchiyama, A. Tsuzuki, K. Tokunaka, N.N. Miura, Y. Adachi, M.W. Aizawa, H. Tamura, S. Tanaka and T. Yadomae. 1999. Solubilization of yeast cell-wall beta-(1 - >3)-D-glucan by sodium hypochlorite oxidation and dimethyl sulfoxide extraction. Carbohydr. Res. 316:161.
20. Ishibashi K., N.N. Miura, Y. Adachi, N. Ogura, H. Tamura, S. Tanaka and N. Ohno. 2002. Relationship between the physical properties of Candida albicans cell well beta-glucan and activation of leukocytes in vitro. Int. Immunopharmacol. 2:1109.
21. Tokunaka K., N. Ohno, Y. Adachi, N.N. Miura and T. Yadomae. 2002. Application of Candida solubilized cell wall beta-glucan in antitumor immunotherapy against P815 mastocytoma in mice. Int. Immunopharmacol. 2:59.
22. Takano H., T. Yoshikawa, T. Ichinose, Y. Miyabara, K. Imaoka and M. Sagai. 1997. Diesel exhaust particles enhance antigen-induced airway inflammation and local cytokine expression in mice. Am. J. Respir. Crit. Care Med. 156:36.
23. Inoue K., H. Takano, A. Shimada, R. Yanagisawa, M. Sakurai, S. Yoshino, H. Sato and T. Yoshikawa. 2004. Urinary trypsin inhibitor protects against systemic inflammation induced by lipopolysaccharide. Mol. Pharmacol. 67:673.
24. Ichinose T., A. Furuyama and M. Sagai. 1995. Biological effects of diesel exhaust particles (DEP). II. Acute toxicity of DEP introduced into lung by intratracheal instillation. Toxicology 99:153.
25. Bradford M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248.
26. Blackwell T.S., T.R. Blackwell, E.P. Holden, B.W. Christman and J.W. Christman. 1996. In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. J. Immunol. 157:1630.
27. Takano H., R. Yanagisawa, T. Ichinose, K. Sadakane, S. Yoshino, T. Yoshikawa and M. Morita. 2002. Diesel exhaust particles enhance lung injury related to bacterial endotoxin through expression of proinflammatory cytokines, chemokines, and intercellular adhesion molecule-1. Am. J. Respir. Crit. Care Med. 165:1329.
28. Abraham E. 2003. Neutrophils and acute lung injury. Crit. Care Med. 31(S):195.
29. Underhill D.M., A. Ozinsky, A.M. Hajjar, A. Stevens, C.B. Wilson, M. Bassetti and A. Aderem. 1999. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401:811.
30. Di Carlo F.J. and J.V. Fiore. 1958. On the composition of zymosan. Science 127:756.
31. Kataoka K., T. Muta, S. Yamazaki and K. Takeshige. 2002. Activation of macrophages by linear (1right-arrow3)-beta-D-glucans. Impliations for the recognition of fungi by innate immunity. J. Biol. Chem. 277:36825.
32. Glovsky M.M., L. Cortes-Haendchen, L. Ghekiere, A. Alenty, D.L. Williams and R. Di Luzio. 1983. Effects of particulate beta-1,3 glucan on human, rat, and guinea pig complement activity. J. Reticuloendothel. Soc. 33:401.
33. Uchiyama M., N. Ohno, N.N. Miura, Y. Adachi, H. Tamura, S. Tanaka and T. Yadomae. 2000. Solubilized cell wall beta-glucan, CSBG, is an epitope of Candida immune mice. Biol. Pharm. Bull. 23:672.
34. Romani L., S. Mocci, C. Bietta, L. Lanfaloni, P. Puccetti and F. Bistoni. 1991. Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance. Infect. Immun. 59:4647.
35. Romani L., A. Mencacci, E. Cenci, R. Spaccapelo, P. Mosci, P. Puccetti and F. Bistoni. 1993. CD4+ subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance. J. Immunol. 150:925.
36. Baggiolini M., P. Loetscher and B. Moser. 1995. Interleukin-8 and the chemokine family. Int. J. Immunopharmacol. 17:103.
37. Nakamura Y. and M. Hoshino. 2005. TH2 cytokines and associated transcription factors as therapeutic targets in asthma. Curr. Drug Targets Inflamm. Allergy 4:267.
38. Levitz S.M., A. Tabuni, S.H. Nong and D.T. Golenbock. 1996. Effects of interleukin-10 on human peripheral blood mononuclear cell responses to Cryptococcus neoformans, Candida albicans, and lipopolysaccharide. Infect. Immun. 64:945.
39. Roeder A., C.J. Kirschning, M. Schaller, G. Weindl, H. Wagner, H.C. Korting and R.A. Rupee. 2004. Induction of nuclear factor- kappa B and c-Jun/activator protein-1 via toll-like receptor 2 in macrophages by antimycotic-treated Candida albicans. J. Infect. Dis. 190:1318.
40. Choi J.H., H.M. Ko, J.W. Kim, H.K. Lee, S.S. Han, S.B. Chun and S.Y. Im. 2001. Platelet-activating factor-induced early activation of NF-kappa B plays a crucial role for organ clearance of Candida albicans. J. Immunol. 166:5139.
41. Foster P.S. 1999. STAT6: an intracellular target for the inhibition of allergic disease. Clin. Exp. Allergy 29:12.